Cormorant Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-295,600
| Closed | -$13.9M | – | 71 |
|
|
2019
Q4 | $13.9M | Hold |
295,600
| – | – | 0.55% | 40 |
|
|
2019
Q3 | $6.99M | Sell |
295,600
-54,400
| -16% | -$1.29M | 0.43% | 46 |
|
|
2019
Q2 | $10.5M | Sell |
350,000
-50,000
| -13% | -$1.5M | 0.6% | 43 |
|
|
2019
Q1 | $8.96M | Sell |
400,000
-41,000
| -9% | -$918K | 0.61% | 42 |
|
|
2018
Q4 | $8.03M | Buy |
+441,000
| New | +$8.03M | 0.65% | 36 |
|